The functional behavior of a macrophage/fibroblast co-culture model derived from normal and diabetic mice with a marine gelatin-oxidized alginate hydrogel

Biomaterials

Volumn 31, Issue 22, 2010, Pages 5772-5781

  Zeng, Qiong ^a   Chen, W ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Co culture; Diabetes; Fibroblast; Hydrogel; Macrophage; Wound dressing

Indexed keywords

ALGINATE HYDROGELS; BIODEGRADABLE MATERIAL; CELL TYPES; CHEMOKINES; CO-CULTURE; CYTOKINES; DIABETES; DIABETIC MICE; FUNCTIONAL BEHAVIORS; IMPLANT INTERFACES; IN-SITU; INFLAMMATORY CYTOKINES; MULTI-FUNCTIONAL; PROTEIN MICROARRAY; QUANTITATIVE DETECTION; WOUND DRESSINGS; WOUND HEALING;

CELL PROLIFERATION; FIBROBLASTS; HYDROGELS; MACROPHAGES; PEPTIDES; TISSUE;

CELL CULTURE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIODEGRADABILITY; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CELLULAR DISTRIBUTION; COCULTURE; CONTROLLED STUDY; DIABETES MELLITUS; FIBROBLAST; HYDROGEL; INCUBATION TIME; MACROPHAGE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; WOUND DRESSING;

ALGINATES; ANIMALS; BANDAGES, HYDROCOLLOID; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; DIABETES MELLITUS, TYPE 2; FIBROBLASTS; GELATIN; GLUCURONIC ACID; HEXURONIC ACIDS; HYDROGEL; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; TISSUE SCAFFOLDS; WOUND HEALING;

MUS;

EID: 77953082946     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.04.022     Document Type: Article

References (43)

1. Choi Y.S., Hong S.R., Lee Y.M., Song K.W., Park M.H., Nam Y.S. Study on gelatin-containing artificial skin: I. Preparation and characteristics of novel gelatin-alginate sponge. Biomaterials 1999, 20(5):409-417.
2. Balakrishnan B., Mohanty M., Umashankar P.R., Jayakrishnan A. Evaluation of an in situ forming hydrogel wound dressing based on oxidized alginate and gelatin. Biomaterials 2005, 26(32):6335-6342.
3. Liao H., Zhang H., Chen W. Differential physical, rheological, and biological properties of rapid in situ gelable hydrogels composed of oxidized alginate and gelatin derived from marine or porcine sources. J Mater Sci Mater Med 2009, 20(6):1263-1271.
4. Morin R.J., Tomaselli N.L. Interactive dressings and topical agents. Clin Plast Surg 2007, 34(4):643-658.
5. Thomas A., Harding K.G., Moore K. Alginates from wound dressings activate human macrophages to secrete tumour necrosis factor-α. Biomaterials 2000, 21(17):1797-1802.
6. Anderson J.M. Biological responses to materials. Annu Rev Mater Res 2001, 31:81-110.
7. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20(2):86-100.
8. Xia Z., Triffitt J.T. A review on macrophage responses to biomaterials. Biomed Mater 2006, 1(1):R1-R9.
9. Jones J.A., Chang D.T., Meyerson H., Colton E., Kwon I.K., Matsuda T., et al. Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells. J Biomed Mater Res A 2007, 83(3):585-596.
10. Pan H., Jiang H.L., Chen W. Interaction of dermal fibroblast with electrospun composite biodegradable polymer scaffolds prepared from dextran and poly-lactide-co-glycolide. Biomaterials 2006, 27(17):3209-3213.
11. Pan H., Jiang H.L., Chen W. The biodegradability of electrospun dextran/PLGA scaffold in a fibroblast/macrophage co-culture. Biomaterials 2008, 29:1583-1592.
12. Maruyama K., Asai J., Ii M., Thorne T., Losordo D.W., D'Amore P.A. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 2007, 170(4):1178-1191.
13. Goren I., Müller E., Schiefelbein D., Christen U., Pfeilschifter J., Mühl H., et al. Systemic anti-TNFα treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. J Invest Dermatol 2007, 127(9):2259-2267.
14. Schmidt D.R., Kao W.J. Monocyte activation in response to polyethylene glycol hydrogels grafted with RGD and PHSRN separated by interpositional spacers of various lengths. J Biomed Mater Res A 2007, 83(3):617-625.
15. Denon D., Kowatch M.A., Roth G.S. Production of wound repair in old mice by local injection of macrophages. Proc Natl Acad Sci USA 1989, 86:2018-2020.
16. Anghelina M., Krishnan P., Moldovan L., Moldovan N.I. Monocytes/macrophages cooperate with progenitor cells during neovascularization and tissue repair: conversion of cell columns into fibrovascular bundles. Am J Pathol 2006, 168(2):529-541.
17. Kerr M.K., Martin M., Churchill G.A. Analysis of variance for gene expression microarray data. J Comput Biol 2000, 7:819-837.
18. Whistler T., Fletcher M.A., Lonergan W., Zeng X.R., Lin J.M., Laperriere A., et al. Impaired immune function in Gulf War Illness. BMC Med Genomics 2009, 2:12-25.
19. Singer A.J., Clark R.A. Cutaneous wound healing. N Engl J Med 1999, 341:738-746.
20. Hubner G., Brauchle M., Smola H., Madlener M., Fässler R., Werner S. Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine 1996, 8:548-556.
21. Wetzler C., Kämpfer H., Stallmeyer B., Pfeilschifter J., Frank S. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 2000, 115(2):245-253.
22. Goren I., Kämpfer H., Podda M., Pfeilschifter J., Frank S. Leptin and wound inflammation in diabetic ob/ob mice: differential regulation of neutrophil and macrophage influx and a potential role for the scab as a sink for inflammatory cells and mediators. Diabetes 2003, 52(11):2821-2832.
23. Grellner W., Georg T., Wilske J. Quantitative analysis of proinflammatory cytokines (IL-1beta, IL-6, TNF-α) in human skin wounds. Forensic Sci Int 2000, 113:251-264.
24. Gallucci R.M., Simeonova P.P., Matheson J.M., Kommineni C., Guriel J.L., Sugawara T., et al. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J 2000, 14:2525-2531.
25. Hattori A., Hayashi K., Kohno M. Tumor necrosis factor (TNF) stimulates the production of nerve growth factor in fibroblasts via the 55-kDa type 1 TNF receptor. FEBS Lett 1996, 379(2):157-160.
26. Gillitzer R., Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol 2001, 69:513-521.
27. Martin P., Leibovich S.J. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 2005, 15(11):599-607.
28. Feugate J.E., Li Q., Wong L., Martins-Green M. The cxc chemokine cCAF stimulates differentiation of fibroblasts into myofibroblasts and accelerates wound closure. J Cell Biol 2002, 156:161-172.
29. Christopherson K., Hromas R. Chemokine regulation of normal and pathologic immune responses. Stem Cells 2001, 19:388-396.
30. Nirodi C.S., Devalaraja R., Nanney L.B., Arrindell S., Russell S., Trupin J., et al. Chemokine and chemokine receptor expression in keloid and normal fibroblasts. Wound Repair Regen 2000, 8(5):371-382.
31. Barrientos S., Stojadinovic O., Golinko M.S., Brem H., Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen 2008, 16(5):585-601.
32. Rovai L.E., Herschman H.R., Smith J.B. The murine neutrophilchemoattractant chemokines LIX, KC, and MIP-2 have distinct induction kinetics, tissue distributions, and tissue-specific sensitivities to glucocorticoid regulation in endotoxemia. J Leukoc Biol 1998, 64(4):494-502.
33. Kyriakides T.R., Foster M.J., Keeney G.E., Tsai A., Giachelli C.M., Clark-Lewis I., et al. The CC chemokine ligand. CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation. Am J Pathol 2004, 165:2157-2166.
34. Zickus C., Kunkel S.L., Simpson K., Evanoff H., Glass M., Strieter R.M., et al. Differential regulation of C-C chemokines during fibroblast-monocyte interactions: adhesion vs. inflammatory cytokine pathways. Mediators Inflamm 1998, 7:269-274.
35. Maurer M., von Stebut E. Macrophage inflammatory protein-1. Int J Biochem Cell Biol 2004, 36(10):1882-1886.
36. DiPietro L.A., Burdick M., Low Q.E., Kunkel S.L., Strieter R.M. MIP1α as a critical macrophage chemoattractant in murine wound repair. J Clin Invest 1998, 101:1693-1698.
37. Hogaboam C.M., Bone-Larson C.L., Lipinski S., Lukacs N.W., Chensue S.W., Strieter R.M., et al. Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derided from Th1- and Th2-type pulmonary granuloma models. J Immunol 1999, 163(4):2193-2201.
38. Groves R.W., Schmidt-Lucke J.A. Recombinant human GM-CSF in the treatment of poorly healing wounds. Adv Skin Wound Care 2000, 13:107-112.
39. Mann A., Breuhahn K., Schirmacher P., Blessing M. Keratinocytederived granulocyte-macrophage colony stimulating factor accelerates wound healing: stimulation of keratinocyte proliferation, granulation tissue formation and vascularization. J Invest Dermatol 2001, 117:1382-1390.
40. Bianchi L., Ginebri A., Hagman J.H., Francesconi F., Carboni I., Chimenti S. Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte-macrophage colony-stimulating factor. J Eur Acad Dermatol Venereol 2002, 16:595-598.
41. Cianfarani F., Tommasi R., Failla C.M., Viviano M.T., Annessi G., Papi M., et al. Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed. Br J Dermatol 2006, 154:34-41.
42. Fang Y., Gong S.J., Xu Y.H., Hambly B.D., Bao S. Impaired cutaneous wound healing in granulocyte/macrophage colony-stimulating factor knockout mice. Br J Dermatol 2007, 157(3):458-465.
43. Yamamoto Y., Kurachi M., Yamaguchi K., Oda T. Stimulation of multiple cytokine production in mice by alginate oligosaccharides following intraperitoneal administration. Carbohydr Res 2007, 342(8):1133-1137.